| Financial Year |
March 31 2023 |
| Monetary Funds |
163,684,163.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
64,079,928.36 |
| Advances to Suppliers |
42,302,735.88 |
| Other Receivables |
7,078,782.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
447,472,937.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,512,499.20 |
| Total Current Assets |
731,131,046.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,909,110.19 |
| Investment Properties |
28,451,336.90 |
| Fixed Assetes |
611,993,415.47 |
| Under-construction Projects |
427,851,309.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
62,207,287.46 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
74,147.20 |
| Deferred Income Tax Assets |
1,536,105.36 |
| Other Non-Current Assets |
9,156,681.91 |
| Sub-Total of Non-Current Assets |
1,143,649,479.97 |
| Total Assets |
1,874,780,526.57 |
| Short-Term Loans |
20,024,144.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
110,216,026.18 |
| Accounts Received In Advance |
2,243,450.55 |
| Employee Compensation Payable |
37,951,667.33 |
| Taxes Payable |
2,638,095.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,534,619.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,500,000.00 |
| Other Current Liabilities |
193,500.97 |
| Sub-Total of Current Liabilities |
257,727,379.03 |
| Long-term Loans |
359,783,114.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,568,726.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
376,342,628.82 |
| Total Liabilities |
634,070,007.85 |
| Paid-In Capital(Or Share Stock) |
266,071,320.00 |
| Capital Surplus |
295,620,272.02 |
| Surplus Reserve |
21,908,064.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
406,759,647.36 |
| Minority Stockholder's Interest |
258,751,721.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
981,958,796.87 |
| Owner's Equity（Stockholder's Equity） |
1,240,710,518.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,874,780,526.57 |
